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Abstract
Background: Orbital apex syndrome (OAS) is a complex and uncommon disorder that typically damages multiple 
cranial nerves in association with optic nerve dysfunction. OAS is associated with several different pathologies, 
however; only a few cases have been reported in association with head and neck cancer (HNC) so far.
Material and Methods: A case series of HNC patients diagnosed with OAS is described including clinicopatho-
logical data, image findings, and disease outcome.
Results: Ptosis and diplopia were diagnosed in four male patients with mean age of 61.2 years who were undergo-
ing treatment for late-stage carcinomas of the tongue, larynx, and nasopharynx, eventually leading to the diagno-
sis of OAS. The mean overall survival rate after the diagnosis of OAS was 9.5 months.
Conclusions: The current study reinforces evidence that OAS indicates poor prognosis and highlights the impor-
tance of early diagnosis. 
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Introduction
Orbital apex syndrome (OAS) is a rare disorder char-
acterized by the involvement and damage of cranial 
nerves, including the oculomotor (III), trochlear (IV), 
abducens (VI) and ophthalmic branch of the trigeminal 
nerve (V) in association with optic dysfunction (1-3). 
OAS may be associated with inflammatory diseases 
(sarcoidosis, systemic lupus, Wegener granulomatosis), 
fungal infections (Mucormycosis, Aspergillus), bacte-
rial infections (Actinomyces, Mycobacterium tuber-
culosis), viral infections (Herpes zoster), primary and 
metastatic tumors (nasopharyngeal carcinoma, neural 
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Patient Gender, age Cancer diagnosis Clinical Stage Cancer treatment Cancer risk factors
1 Male, 73 years old
Tongue (lateral 
border) squamous 
cell carcinoma
T3N2bM0
Partial Glossectomy 
and radical bilateral 
neck dissection; 3D 
conformal radiothera-
py (66 Gy); chemother-
apy (Carboplatin)
Tobacco (20 cigarettes/
day, during 57 years) and 
alcohol (1 L distilled spir-
its/day, during 50 years) 
consumption
2 Male, 70 years old
Larynx squamous 
cell carcinoma T4N3M0
3D conformal radio-
therapy (70 Gy)
Tobacco (40 cigarettes/
day, during 10 years) and 
alcohol (1.5 L distilled 
spirits/day, during 50 
years) consumption 
3 Male, 53 years old
Nasopharyngeal 
carcinoma
T4N3M1
(liver metastasis)
Palliative treatment: 
3D conformal radio-
therapy (40 Gy); che-
motherapy (Cisplatin 
and 5 fluorouracil)
 
Tobacco (20 cigarettes/
day, during 12 years) and 
alcohol (1 L distilled spir-
its/day, during 12 years) 
consumption
4 Male, 49 years old
Nasopharyngeal 
carcinoma
T4N3M1
(bone metastasis)
Palliative treatment: 
3D conformal radio-
therapy (30 Gy); che-
motherapy (Cisplatin 
and 5-fluorouracil) 
Tobacco (20 cigarettes/
day during 30 years) 
smoking
tumors, metastatic tumors, lymphomas and leukemia) 
as well as trauma (sinonasal surgery), among others 
(mucoceles) (1,2). 
From a clinical point of view, patients diagnosed with 
OAS initially present visual loss and ophthalmoplegia, 
such as proptosis, ptosis, fixed dilated pupil, and diplo-
pia. Associated periorbital pain may also develop in 
these patients (1-3). 
Apparently, the association of OAS and head and neck 
cancer (HNC) is considered to be exceptionally rare, 
with only a few cases published in the English-related 
literature so far (4,5). Therefore, the aim of the present 
case series was to report four additional cases of OAS 
diagnosed in patients undergoing treatment for ad-
vanced carcinomas of the head and neck region, includ-
ing tumors of the tongue, larynx, and nasopharyns. In 
addition, clinic and image data relevant for diagnosis 
will be discussed in the light of the scientific literature 
pertinent to OAS.
Material and Methods
This is a retrospective case description report based on 
patients who were undergoing dental treatment at the 
Dental Oncology Service of the Instituto do Cancer do 
Estado de Sao Paulo (ICESP), from March 2011 to Janu-
ary 2013. In order to be included in this case series, the 
patients had to present a confirmed diagnosis of HNC 
and develop ocular alterations or ophthalmoplegia. 
Complete medical information including demographic 
and clinicopathologic data, diagnostic head and neck 
imaging and post-cancer treatment follow-up also had 
to be complete and fully available at the patients’ medi-
cal charts. 
This retrospective study was reviewed and approved by 
the Ethics Committee of the University of Sao Paulo 
Medical School, Sao Paulo, Brazil (study protocol num-
ber 882,731). 
Results
Four patients with a previous history of head and neck 
carcinomas were included in this case series. All of the 
patients were men, with a mean age of 61.2 years at the 
time of diagnosis, presenting advanced stage tumors 
with a previous history of tobacco and alcohol con-
sumption. Detailed demographic and clinicopathologi-
cal information are presented in tables 1 and 2. Illustra-
tive images of the patients are presented in figures 1,2 
and 3.
Discussion
HNC is the sixth most common cancer worldwide (6,7), 
accounting for an annual incidence of approximately 
700,000 cases (nearly 5% of all cancers) and almost 
375,000 deaths (7). HNC primarily affects men between 
the sixth and the seventh decades of life. Smoking and 
alcohol use are the major risk factors (8). In accordance 
Table 1. Demographic and clinicopathological features of head and neck cancer patients diagnosed with orbital apex syndrome.
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Patient Diagnosis timing Ocular alteration Image features
Involved 
Cranial Nerve Medical follow-up
1
4 months after 
chemoradio-
therapy
Diplopia; facial 
paresthesia (right side, 
ipsilateral to tumor) 
{Figure 1A}
Computed tomography: 
hyperdense image 
localized in the base of 
the skull associated with 
destruction of the right 
sphenoid bone 
(Figure 1B)
Abducens  (VI)
Disease 
progression with 
progressive ptosis 
and sensory ataxia 
(denied pain); died 
9 months after the 
diagnosis of OAS
2
During 
radiotherapy 
(19th session, 
38 Gy)
Ptosis; 
ophthalmoplegia and 
hearing loss (left side, 
ipsilateral to 
tumor) {Figure 2A}
Computed tomography: 
thickening of the left 
pinna and external 
conduit (Figure 2B)
Oculomotor (III);
Vestibulocochlear 
(VIII)
Died 9 months 
after the diagnosis 
of OAS
3
During 
radiotherapy 
(2nd session, 5 
Gy)
Ptosis; blurred vision; 
mydriasis and 
ophthalmoplegia (left 
side, ipsilateral to 
tumor) {Figure 3A}
Magnetic resonance 
imaging: hyperintense 
image at the skull base 
causing enlargement of 
the left optical canal and 
destruction of the left 
sphenoid bone 
(Figure 3B)
Oculomotor (III)
Died 9 months 
after the diagnosis 
of OAS
4
Concomitant 
to cancer 
diagnosis
Diplopia; progressive 
visual loss (left side, 
ipsilateral to tumor) 
{Figure 3C}
Magnetic resonance 
imaging: mass involving 
the left sphenoid bone 
and causing hypoglossal 
canal obliteration 
(Figure 3D)
Trochlear (IV);
Hypoglossal (XII)
Died 11 months 
after the diagnosis 
of OAS
Table 2. Clinicopathological features of orbital apex syndrome in head and neck cancer patients.
Fig. 1. A. Extraoral clinical aspect showing right eyelid ptosis. B. Axial CT (soft-tissue window display) demonstrating an extensive 
hyperdense image at the base of the skull associated with the sphenoid bone.
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with the above-mentioned literature, all the patients in 
the current series were elderly men with a previous his-
tory of tobacco and alcohol abuse. 
HNC patients tend to present a loco-regional spread of 
disease; the most common site of metastasis is the re-
gional neck lymph nodes. Distant metastasis from HNC 
is considered a rare event (9-11). Kowalski et al. (10) 
evaluated 2,327 patients diagnosed with HNC and found 
that only 3.8% of the patients had distant metastasis, 
while Alvi et al., (9) reported a distant metastasis rate 
of 23%. Lung and bone were the most common distant 
sites for distant metastasis in both studies. Accordingly, 
advanced HNCs affected all of the patients included in 
the present case series.
The association between OAS and HNC is unusual. In 
this context, Whirth et al., (5) recently reported a case 
Fig. 2. A. Extraoral clinical image of the left eyelid ptosis. B. Axial CT (bone-window display) showing a thickening of the left 
pinna and external ear conduit.
Fig. 3. Patient 3. A. Extraoral clinical aspect showing left eyelid ptosis. B. Axial 
IMR (T2-weighted) demonstrating hyperintense image at the skull base caus-
ing enlargement of the left optical canal. Patient 4. C. Extraoral clinical aspect 
revealing fixed globe in the left eye. D. Axial IMR (T2-weighted) demonstrating 
a mass involving the left sphenoid bone and causing hypoglossal canal oblitera-
tion.
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of oral squamous cell carcinoma associated with oph-
thalmoplegia and severe general facial pain, leading to 
the diagnosis of OAS. Aryasit et al. (2) performed a ret-
rospective review of patients diagnosed with OAS and 
observed that 48% of which had associated neoplasias 
were lymphomas (37.5%) was the most common tumor 
followed by meningiomas (29.2%). Apparently, the inci-
dence of the association between HNC and OAS is cur-
rently unknown and, when judging the cases presented 
herein, one could suggest that this association might be 
unrecognized and might not be as rare as once believed.
Patients diagnosed with OAS usually present with vis-
ual impairment and ophthalmoplegia, including prop-
tosis, ptosis and periorbital pain. The diagnosis of OAS 
is clinical; however, a detailed history and physical 
examination should be performed (12,13). Imaging is 
important in discerning the causative etiology (2,3). In 
the current case series, all the patients presented ocular 
alterations, including two patients presenting diplopia 
and two other presenting ptoses. 
Most of the patients diagnosed with distant metastasis 
of HNC are considered to be incurable and are often 
treated by palliative care protocols, such as chemother-
apy or radiotherapy (10). According to Alvi et al. (9), 
the average overall survival rate after the diagnosis of 
distant metastasis of HNC is 5 months, while Kowal-
ski et al. (10) reported a rate of 1.8 months in patients 
with bone metastasis. In the present case series, the av-
erage overall survival rate after the diagnosis of skull 
metastasis (or infiltration) associated with OAS was 9.5 
months. The present results reinforce previous evidence 
that OAS is a marker of poor disease outcome in cancer 
patients and emphasize the need for prompt identifica-
tion of clinical signals of OAS in HNC patients (2). 
Overall, up to 80% of all HNC patients are diagnosed 
with advanced stages of the disease, presenting poor 
prognoses and requiring aggressive multimodality 
treatment (7,12,14) in association with multidisciplinary 
supportive care where dental oncologists may contrib-
ute to the early diagnosis of the disease relapse or rel-
evant complications of tumor progression, such as OAS. 
Thus, this case series highlights the importance of in-
teractions among dentists, oncologists, and physicians 
involved in HNC treatment to improve the early recog-
nition of OAS and promote patient prognosis. 
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